This site is intended for customers within the United States. | Switch to: Outside the United States
nav_patient nav_physician

Text Size: SM / MD / LG

Toric lens stability is crucial to maintaining optimal astigmatism correction.(2) The TECNIS® Toric IOL exceeds the ANSI (American National Standards Institute) criteria for toric lens rotational stability.(1)

ANSI standard Z80.30-2010 requires that ≥ 90% of eyes experience a change in axis of ≤ 5° between two consecutive visits approximately three months apart.
The below information highlights key data from the Multicenter IDE study.

EXCEPTIONAL ROTATIONAL STABILITY

Excellent Post-op Rotational Stability
94% of eyes implanted with TECNIS® Toric IOLs had a change in axis of ≤ 5° between two consecutive visits approximately three months apart.(1)

Minimal Mean Axis Change
Average rotation between baseline and six months was an exceptional 2.74°(1)

EXCELLENT UCDVA, RESIDUAL REFRACTIVE CYLINDER, AND PATIENT SATISFACTION

Improved Uncorrected Distance Visual Acuity(1)
Nearly 9 out of 10 patients achieved 20/32 or better uncorrected distance visual acuity(1)

Reduced Residual Refractive Cylinder(1)
94.1% of patients implanted achieved ≤ 1.00 diopters of residual refractive cylinder. 72.3% achieved ≤ 0.50 diopters(1)

An Impressive 97% of Patients Would Choose to Have the TECNIS® Toric IOL Again(1)

Unique Advantages set the TECNIS® Toric IOL Apart

  • Exclusive Tri-Fix 3-Point Fixation Design, including contact points at both haptics and the posterior side of the optic, supports long-term rotational stability and optimal outcomes
  • Optical Synergy, a compelling combination of aspheric optics, clear lens material, and precision-engineered design, helps provide patients with sharper vision,(1,3,26) outstanding visual acuity,(1,3) improved scotopic sensitivity and transmission of healthy blue light,(14) plus reduced lens epithelial (LEC) migration(25,27-29)
  • The Patient-centric TECNIS® Toric IOL Calculator is uniquely engineered to enable greater individualization and customization.

Visit the TECNIS Toric Calculator


For complete product specifications, click here.



Indications and Important Safety Information

TECNIS® Toric IOL

Indications
The TECNIS® Toric 1-Piece posterior chamber lenses are indicated for the visual correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire improved uncorrected distance vision, reduction in residual refractive cylinder, and increased spectacle independence for distance vision. The device is intended to be placed in the capsular bag.

Warnings
Physicians considering lens implantation should weigh the potential risk/benefit ratio for any circumstances described in the TECNIS® Toric 1-Piece IOL Directions for Use that could increase complications or impact patient outcomes. These circumstances include recurrent severe anterior or posterior segment inflammation or uveitis; surgical difficulties at the time of cataract extraction, which may increase the potential for complications (e.g., persistent bleeding, significant iris damage, uncontrolled positive pressure or significant vitreous prolapse or loss); a compromised eye due to previous trauma or developmental defects in which appropriate support of the IOL is not possible; circumstances that would result in damage to the endothelium during implantation; suspected microbial infection; or patients in whom neither the posterior capsule nor the zonules are intact enough to provide support for the IOL. Children under the age of 2 years are not suitable candidates for intraocular lenses. The clinical study for the TECNIS® Toric 1-Piece IOL did not show evidence of effectiveness for the treatment of preoperative corneal astigmatism of less than one diopter. The TECNIS® Toric 1-Piece IOL should not be placed in the ciliary sulcus. Rotation of the TECNIS® Toric 1-Piece IOL away from its intended axis can reduce its astigmatic correction. Misalignment greater than 30° may increase postoperative refractive cylinder. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation.

Precautions
Prior to surgery, the surgeon must inform prospective patients of the possible risks and benefits associated with the use of this device and provide a copy of the patient information brochure to the patient. Do not soak or rinse with any solution other than sterile balanced salt solution or sterile normal saline. Do not store in direct sunlight or at greater than 113ºF. Carefully remove all viscoelastic and do not over-inflate the capsular bag at the end of the case. Residual viscoelastic and/or over-inflation of the capsular bag may allow the lens to rotate, causing misalignment of the TECNIS® Toric 1-Piece IOL with the intended axis of placement. When the insertion system is used improperly, the haptics of the TECNIS® Toric 1-Piece IOL may become broken. Please refer to the specific instructions for use provided with the insertion instrument or system. The use of methods other than the TECNIS Toric Calculator to select cylinder power and appropriate axis of implantation were not assessed in the clinical study and may not yield similar results. Accurate keratometry and biometry in addition to the use of the TECNIS Toric Calculator (www.TecnisToricCalc.com) are recommended to achieve optimal visual outcomes. The safety and effectiveness of the toric intraocular lens have not been substantiated in patients with certain preexisting ocular conditions, and intraoperative complications. Preexisting conditions include: choroidal hemorrhage, chronic severe uveitis, concomitant severe eye disease, extremely shallow anterior chamber, medically uncontrolled glaucoma, microphthalmos, non-age-related cataract, proliferative diabetic retinopathy (severe), severe corneal dystrophy, severe optic nerve atrophy, or irregular corneal astigmatism. Intraoperative conditions include: excessive vitreous loss, capsulotomy by any technique other than a circular tear, the presence of radial tears known or suspected at the time of surgery, situations in which the integrity of the circular tear cannot be confirmed by direct visualization, cataract extraction by techniques other than phacoemulsification or liquefaction, situations where the need for a large capsulotomy can be anticipated (e.g., diabetics, retinal detachment in the fellow eye, peripheral retinal pathology, etc.), capsular rupture, significant anterior chamber hyphema, uncontrollable positive intraocular pressure, and zonular damage. All preoperative surgical parameters are important when choosing a toric lens for implantation, including preoperative keratometric cylinder (magnitude and axis), incision location, surgeon’s estimated surgically induced astigmatism (SIA) and biometry. Variability in any of the preoperative measurements can influence patient outcomes and the effectiveness of treating eyes with lower amounts of preoperative corneal astigmatism. All corneal incisions were placed temporally in the clinical study. If the surgeon chooses to place the incision at a different location, outcomes may be different from those obtained in the clinical study. Note that the TECNIS Toric Calculator incorporates the surgeon’s estimated SIA and incision location when providing IOL options. Do not reuse, resterilize, or autoclave.

Adverse Events
Potential adverse events during or following cataract surgery with implantation of an IOL may include but are not limited to: endophthalmitis/intraocular infection, hypopyon, pupillary block, retinal detachment, IOL dislocation, persistent corneal stromal edema, persistent cystoid macular edema, or secondary surgical intervention (including implant repositioning, removal, or other surgical procedure). The most frequently reported adverse event that occurred during the clinical trial of the TECNIS® Toric 1-Piece IOL was surgical reintervention, which occurred at a rate of 3.4% (lens repositioning procedures and retinal repair procedures). Other reported events included macular edema, which occurred at a rate of 2.9%, and retinal detachment, which occurred at a rate of 0.6%.

Caution
Federal law restricts this device to sale by or on the order of a physician.



References
1. TECNIS Toric 1-Piece IOL [package insert]. Santa Ana, Calif: Abbott Medical Optics Inc.
2. Novis C. Astigmatism and toric intraocular lenses. Curr Opin Ophthalmol. 2000; 11:47–50.
3. TECNIS Foldable Acrylic IOL with OptiEdge Design [package insert]. Santa Ana, Calif: Abbott Medical Optics Inc.
14. Mainster MA. Violet and blue-light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90:784–792.
25. Nixon DR. New technologies for premium outcomes: next generation phaco and TECNIS® 1-Piece IOL. Presented at: 25th Congress of ESCRS; September 8–12,2007; Stockholm, Sweden.
26. Terwee T, van der Mooren M, Piers P. Optical performance of TECNIS® IOLs compared with IOLs that partly compensate for the mean SA of the human cornea. Presented at: Annual Meeting of the American Society of Cataract and Refractive Surgery; 2008 Apr 4–9; Chicago.
27. Sacu S, Menapace R, Buehl W, Rainer G, Findl O. Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction. J Cataract Refract Surg. 2004;30:1875-1882.
28. Boyce JF, Bhermi GS, Spalton DJ, El-Osta AR. Mathematical modeling of the forces between an intraocular lens and the capsule. J Cataract Refract Surg. 2002;28(10):1853-1859.
29. Peng Q, Visessook N, Apple DJ, et al. Surgical prevention of posterior capsule opacification. Part 3: Intraocular lens optic barrier effect as a second line of defense. J Cataract Refract Surg. 2000;26(2):198-213.


Instructions For Use (Click below for the full version)

TECNIS® Toric IOL (PDF)

Back to Top of Page

LegalPrivacy PolicyTerms of Use
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
©2013 Abbott Laboratories Inc. Abbott Park, Illinois, USA  www.AbbottMedicalOptics.com